Fintech Firm Blend Labs Seeks US$360 Million In IPO

Blend Labs Inc. announced this morning the launch of its initial public offering on the New York Stock Exchange. The company will be offering 20.0 million Class A stocks on the big board under the symbol “BLND”.

The offering price is expected to be between US$16.00 to US$18.00 per share for potential total aggregate proceeds of up to US$360.0 million. The financial software company also gave the underwriters a 30-day option to purchase an additional 3,000,000 common shares.

In the prospectus filed, the San Francisco-based fintech company recorded US$31.9 million in revenue and a US$27.1 million net loss for Q1 2021. The company also raised US$300.0 million in its last round of funding in January 2021, putting the company’s valuation at US$3.3 billion. The proposed public offering seeks to bring this up to US$3.95 billion.

Goldman Sachs & Co., Allen & Company, and Wells Fargo Securities are all managing the offering as lead underwriters. 


Information for this briefing was found via Blend. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Copper Junior Just Secured $96 Million | Simon Quick – Canadian Copper

This Gold Stock Just Doubled — And It Still Looks Cheap | Q-Gold Resources PEA

Silver May Be the Trade of This Crisis | Michael Oliver

Recommended

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Kirkland Lake Drills 121 Metres Of 1.01 g/t Gold At Mirado

Related News

Consumer Goods SPAC Conyers Park III Acquisition Seeks To Raise US$350 Million In IPO

Special purpose acquisition company Conyers Park III Acquisition Corp. (Nasdaq: CPAAU) went public on Nasdaq...

Tuesday, August 10, 2021, 02:12:00 PM

Grill Maker Weber Prices Downsized US$250 Million IPO

Grill maker Weber Inc. (NYSE: WEBR) started publicly trading on the New York Stock Exchange...

Thursday, August 5, 2021, 03:37:00 PM

Asia-Focused Biotech SPAC Valuence Merger I Prices US$200 Million IPO

Special purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq...

Tuesday, March 1, 2022, 02:26:00 PM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

Renewable Energy SPAC Enphys Acquisition Prices Upsized US$300 Million IPO

Blank check company Enphys Acquisition Corp. (Nasdaq: NFYS.U) went public today on the Nasdaq Global...

Wednesday, October 6, 2021, 02:26:00 PM